Elevated Intracranial Pressure in Cryptococcal Meningoencephalitis: Examining Old, New, and Promising Drug Therapies

Area of Science:

• Neuroscience
• Infectious Diseases
• Pharmacology

Background:

• Cryptococcal meningoencephalitis (CM) is a severe fungal infection of the central nervous system (CNS).
• High fungal burden in the CNS leads to intracranial hypertension (ICH), a major cause of mortality.
• Current management of ICH, primarily via cerebrospinal fluid drainage, is invasive and limited in resource-poor settings.

Purpose of the Study:

• To explore potential pharmacologic therapies for managing intracranial pressure (ICP) in cryptococcal meningoencephalitis (CM).
• To identify drug classes that could reduce cerebrospinal fluid production or enhance resorption.
• To improve clinical outcomes for patients with CM, particularly in resource-limited settings.

Main Methods:

• This is a discussion of potential therapeutic strategies.
• Review of existing pharmacologic agents used to decrease ICP in other neurological conditions.
• Exploration of diuretics, corticosteroids, and antiepileptic agents for CM treatment.

Main Results:

• No direct results from a clinical trial are presented.
• The discussion highlights the theoretical benefits of pharmacologic ICP management.
• Identifies drug classes with potential application in reducing ICP in CM.

Conclusions:

• Pharmacologic interventions targeting cerebrospinal fluid dynamics offer a promising avenue for managing ICH in CM.
• Such therapies could provide a less invasive and more accessible alternative to current ICP management strategies.
• Further research into these drug classes for CM is warranted to improve patient survival rates.